These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18219364)

  • 1. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1.
    Huther A; Dietrich U
    AIDS Rev; 2007; 9(4):208-17. PubMed ID: 18219364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 by a peptide ligand of the genomic RNA packaging signal Psi.
    Dietz J; Koch J; Kaur A; Raja C; Stein S; Grez M; Pustowka A; Mensch S; Ferner J; Möller L; Bannert N; Tampé R; Divita G; Mély Y; Schwalbe H; Dietrich U
    ChemMedChem; 2008 May; 3(5):749-55. PubMed ID: 18205165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide derived from cobra venom inhibits HIV infection.
    AIDS Read; 2000 May; 10(5):282. PubMed ID: 10851717
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs.
    Waters L; Nelson MR
    J HIV Ther; 2005 Mar; 10(1):16-8. PubMed ID: 15951730
    [No Abstract]   [Full Text] [Related]  

  • 5. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2007 Feb; 15(4):1725-31. PubMed ID: 17178227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent, but deadly--eliminating reservoirs of latent HIV.
    Kay MS
    Trends Biotechnol; 2003 Oct; 21(10):420-3. PubMed ID: 14512225
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal frameshifting: an emerging drug target for HIV.
    Gareiss PC; Miller BL
    Curr Opin Investig Drugs; 2009 Feb; 10(2):121-8. PubMed ID: 19197789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
    Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
    Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatment options for pediatric HIV infection.
    Day E; Buckberry K; Sharland MR; Chakraborty R
    Curr Opin Investig Drugs; 2008 Feb; 9(2):170-5. PubMed ID: 18246519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New in silico and conventional in vitro approaches to advance HIV drug discovery and design.
    Maga G; Veljkovic N; Crespan E; Spadari S; Prljic J; Perovic V; Glisic S; Veljkovic V
    Expert Opin Drug Discov; 2013 Jan; 8(1):83-92. PubMed ID: 23167743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary HIV infection: therapeutic strategies.
    Capiluppi B; Castelli E; Clerici E; Pan A; Tomasoni L; Lazzarin A
    J Biol Regul Homeost Agents; 1997; 11(1-2):56-9. PubMed ID: 9418164
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues.
    Oishi S; Kamitani H; Kodera Y; Watanabe K; Kobayashi K; Narumi T; Tomita K; Ohno H; Naito T; Kodama E; Matsuoka M; Fujii N
    Org Biomol Chem; 2009 Jul; 7(14):2872-7. PubMed ID: 19582296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic helical peptides containing two acridine moieties display picomolar affinity toward HIV-1 RRE and TAR.
    Lee Y; Hyun S; Kim HJ; Yu J
    Angew Chem Int Ed Engl; 2008; 47(1):134-7. PubMed ID: 17987636
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid-binding small molecule reduces HIV infection.
    Future Med Chem; 2010 Nov; 2(11):1623. PubMed ID: 21428833
    [No Abstract]   [Full Text] [Related]  

  • 17. Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy.
    Veselovsky AV; Zharkova MS; Poroikov VV; Nicklaus MC
    SAR QSAR Environ Res; 2014; 25(6):457-71. PubMed ID: 24716798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forgiveness of non-adherence to HIV-1 antiretroviral therapy.
    Shuter J
    J Antimicrob Chemother; 2008 Apr; 61(4):769-73. PubMed ID: 18256112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.
    Zeng LF; Zhang HS; Wang YH; Sanchez T; Zheng YT; Neamati N; Long YQ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4521-4. PubMed ID: 18662877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.